|
Aug 27
|
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?
|
|
Aug 7
|
Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results
|
|
Aug 6
|
Context Therapeutics Inc.'s (NASDAQ:CNTX) top owners are individual investors with 52% stake, while 30% is held by private equity firms
|
|
Jun 12
|
Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?
|
|
May 20
|
Are You Looking for a Top Momentum Pick? Why Context Therapeutics Inc. (CNTX) is a Great Choice
|
|
Nov 9
|
Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
|
|
Aug 10
|
Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
|
|
Aug 9
|
Context Therapeutics Reports Second Quarter 2023 Operating and Financial Results
|
|
Apr 24
|
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
|